Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NAPPA study
2013-002366-40Phase 4Unknown
- Sponsor
- St George's, University of London
- Start
- Jun 2013
- Modality
- Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of amoxicillin, ampicillin, benzylpenicillin, amoxicillin + clavulanate, flucloxacillin and 1 more in bacterial disease and surgical prophylaxis (6 cohorts), sponsored by St George's, University of London. Primary endpoints: Drug clearance and Volume of distribution. Status: unknown.
02
Drugs
amoxicillinampicillinbenzylpenicillinamoxicillin + clavulanateflucloxacillin
03
Conditions
bacterial diseasesurgical prophylaxis
Beyond the preview
Go deeper on 2013-002366-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-002366-40.